Apotex launches nilotinib capsules, the first generic version of Tasigna®(1) in the United States, with 180 days of exclusivity
Nilotinib is a kinase inhibitor indicated to treat certain types of leukemia, including newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia ("Ph+ CML") in chronic phase in adults and children aged 1 year and older. It is also indicated for adults and pediatric patients with chronic or accelerated phase Ph+ CML with resistance or intolerance to prior therapy, demonstrating higher efficacy compared with other available treatments.
"The launch of nilotinib highlights our commitment to providing affordable, high-quality, critical medications to patients in need," said Christine Baeder, President, Apotex USA. "By offering the first generic version of this important leukemia treatment, we improve access and outcomes for both adult and pediatric patients facing this serious disease."
Please refer to the complete prescribing information, patient information leaflet, warnings and precautions, adverse reactions, and contraindications.
About Apotex
Apotex Corp., headquartered in Weston, Florida, is an affiliate of Apotex Inc. We improve everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic and innovative pharmaceutical and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions.
Learn more about us at www.apotex.com.
SOURCE Apotex Inc.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Canada News.Net
37 minutes ago
- Canada News.Net
Trump slaps tariffs on key allies as global trade talks intensify
WASHINGTON, D.C.: With the clock ticking toward a self-imposed trade deal deadline, U.S. President Donald Trump has announced steep tariffs on dozens of countries, escalating his efforts to reshape the global trade landscape. Through an executive order issued this week, Trump imposed new import duties ranging from 10 percent to 50 percent on goods from 69 trading partners, including Canada, Brazil, India, Taiwan, and Switzerland. The tariffs will take effect in seven days, just ahead of the August 1 deadline. The measures include a 35 percent tariff on many Canadian goods, 50 percent for Brazil, 25 percent for India, and 20 percent for Taiwan. An exception has been granted for shipments already in transit. Goods from countries not listed will face a blanket 10 percent U.S. import tax, potentially more in the future, Trump indicated. "Some trading partners, despite having engaged in negotiations, have offered terms that, in my judgment, do not sufficiently address imbalances," the executive order stated, adding some also failed to align with U.S. economic and national-security priorities. Markets reacted with relative calm, a contrast to the selloff that followed Trump's earlier tariff threats in April. Still, stocks and equity futures edged lower in Asian trading. The administration says additional trade deals are in the works as part of a broader strategy to close trade deficits and support U.S. manufacturing. Canada was hit particularly hard. Trump raised tariffs on Canadian goods tied to fentanyl-related enforcement to 35 percent, up from 25 percent, claiming Ottawa had "failed to cooperate" on narcotics enforcement. "Canada has been very poorly led," Trump told reporters. Canada's government has not yet responded, but it previously contested the basis for such tariffs. Mexico, meanwhile, received a reprieve. Trump granted a 90-day delay on new 30 percent tariffs for most Mexican non-automotive and non-metal goods covered by the U.S.-Mexico-Canada Agreement (USMCA), following a call with President Claudia Sheinbaum. "We avoided the tariff increase announced for tomorrow," Sheinbaum posted on X, calling the call with Trump "very good." However, U.S. tariffs on Mexican steel, aluminum, copper, and non-USMCA-compliant autos remain in place. India now faces a 25 percent tariff following stalled negotiations over agricultural market access. Trump also raised concerns about India's purchases of Russian oil. Talks are ongoing, but New Delhi has pledged to protect its farm sector. The news triggered backlash from India's opposition and a drop in the rupee. Brazil was hit with a 50 percent tariff amid tensions over the prosecution of former President Jair Bolsonaro, a Trump ally. Still, specific sectors such as energy, aircraft, and orange juice were spared. Commerce Department data showed that tariffs may already be driving up prices: home furnishings rose 1.3 percent in June, recreational goods 0.9 percent, and clothing and footwear 0.4 percent. Meanwhile, Trump's legal justification, using the 1977 International Emergency Economic Powers Act, faced tough questioning in federal court. Judges appeared skeptical that trade deficits and fentanyl enforcement constitute emergencies under the law. Following preliminary progress in earlier talks, China now has until August 12 to finalize a broader tariff agreement with Washington.
Canada News.Net
7 hours ago
- Canada News.Net
Cocoa tariffs crush US firms, boost Canadian chocolate exports
LONDON/NEW YORK: U.S. President Donald Trump's tariffs are designed to strengthen domestic manufacturing. But in the chocolate industry, they're having the opposite effect, raising cocoa import costs and making U.S. production less competitive than factories in Canada and Mexico, industry executives and experts say. Thanks to the U.S.-Mexico-Canada Agreement (USMCA), chocolate exported to the U.S. from Canada and Mexico is tariff-free, regardless of where the cocoa is sourced. Meanwhile, U.S. manufacturers must now pay between 10 percent and 25 percent in tariffs on cocoa imports. Those rates could rise to 35 percent starting August 1. Canada has no tariffs on imported cocoa products like butter and powder, and Mexico grows its own beans, giving both countries a cost advantage over U.S.-based factories. Top U.S. chocolate producer Hershey, which has facilities in Canada and Mexico, estimated earlier that tariffs could cost it US$100 million in the second half of this year if they remain in place. The company recently introduced double-digit price hikes on products like Reese's cups, but said the increases were not related to tariffs. Smaller producers are also feeling the pressure. Taza Chocolate, based in Somerville, Massachusetts, had to pay over $24,000 in duties for a single container of cocoa from Haiti. Its next shipment from the Dominican Republic will cost more than $30,000 in tariffs. "For a company our size, that's our profit margin gone," said CEO Alex Whitmore. While he considered moving part of the production to Canada to benefit from USMCA, the investment was too risky in today's uncertain environment. "We're just hunkering down and hoping this will pass," he said. Customs data from Trade Data Monitor shows Canada's chocolate exports to the U.S. rose 10 percent in the first five months of this year. Industry insiders say Canadian and Mexican contract manufacturers are gaining market share, including multinationals like Barry Callebaut, which operates multiple facilities across North America. Barry Callebaut declined to comment, but CEO Peter Feld noted the company's presence in the U.S., Canada, and Mexico "allows us to navigate this environment." Contract chocolate makers supply raw chocolate to U.S. brands, which then add ingredients and market it as American-made. The timing is especially tough for U.S. chocolate makers. Cocoa prices have surged due to poor weather and disease in major producing countries like Ghana and the Ivory Coast. Cocoa accounts for 30 to 50 percent of a chocolate bar's total cost. Hershey said in May that it is lobbying the U.S. government for an exemption on cocoa imports. In Mexico, the chocolate association Aschoco Confimex said American companies have shown growing interest in outsourcing production south of the border. "The sentiment… and requests… to manufacture in Mexico is real and has been increasing," said director general Paolo Quadrini. The U.S. chocolate market is worth $25 to 30 billion. Imports from Canada and Mexico now make up roughly 12.5 percent of that total.
Toronto Star
7 hours ago
- Toronto Star
This surgeon was ‘essentially experimenting on patients without their consent.' He was allowed to keep treating — and allegedly harming — patients
Updated 5 mins ago Aug. 2, 2025 9 min read Save By Shree ParadkarInvestigative Reporter When Taissa Pavliuc got a referral to the North York Endoscopy Centre, she went, hoping she could get the treatment she needed to return to competing in triathlons. A surgeon at the clinic, Dr. Ashwin Maharaj, had been billed online as 'a leading expert in minimally invasive hemorrhoid and anorectal surgery.' ARTICLE CONTINUES BELOW Shree Paradkar is a Toronto-based investigative reporter for the Star. Follow her on X: @ShreeParadkar. Related Stories Disturbing errors at Ontario fertility clinics destroy couples' baby dreams years after province abandoned oversight plans Toronto doctor who sexually abused patients has 'greatly' harmed medical profession, but will keep license after third suspension Search the Star's database of Ontario's top-billing doctors Report an error Journalistic Standards About The Star More from The Star & partners
